Latest Drug design Stories
LONDON and BOSTON, January 22, 2015 /PRNewswire/ -- Stable Receptor, X-ray Structure and Hit Series Generated for PAR2, a Previously
RESEARCH TRIANGLE PARK, N.C., Sept.
NEW YORK, Sept.
Phase I Project to Focus on Advanced Molecular Search Models for the Inverse Design Computational Drug Discovery Platform RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ --
Dehydrons are defects in protein structure that promote protein associations.
Researchers to Use IBM Blue Gene/Q Supercomputer for Computational Drug Design and Discovery RESEARCH TRIANGLE PARK, N.C., July 14, 2014 /PRNewswire/ -- Cloud Pharmaceuticals,
Scientists at Stanford University and the Department of Energy's SLAC National Accelerator Laboratory have found a way to estimate uncertainties in computer calculations that are widely used to speed the search for new materials for industry, electronics, energy, drug design and a host of other applications.
New name better reflects company's cloud-based approach to drug design and development RESEARCH TRIANGLE PARK, N.C., June 12, 2014 /PRNewswire/ -- TeraDiscoveries, Inc., a bio-therapeutics
LONDON and BOSTON, May 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Fiona Marshall,
- A poem in which the author retracts something said in an earlier poem.